SI9200228B - Imidazolyl-alkenoic acids - Google Patents

Imidazolyl-alkenoic acids Download PDF

Info

Publication number
SI9200228B
SI9200228B SI9200228A SI9200228A SI9200228B SI 9200228 B SI9200228 B SI 9200228B SI 9200228 A SI9200228 A SI 9200228A SI 9200228 A SI9200228 A SI 9200228A SI 9200228 B SI9200228 B SI 9200228B
Authority
SI
Slovenia
Prior art keywords
medicament
manufacture
treatment
compound according
imidazolyl
Prior art date
Application number
SI9200228A
Other languages
Slovenian (sl)
Other versions
SI9200228A (en
Inventor
Keenan Richard Mcculloch
Joseph Weinstock
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Priority to SI9200228A priority Critical patent/SI9200228B/en
Publication of SI9200228A publication Critical patent/SI9200228A/en
Publication of SI9200228B publication Critical patent/SI9200228B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (6)

1 Patentni zahtevki 1. Spojina, ki je metansulfonat (E)-3-[2-n-butil-l-{(4-karboksinaft-l-il)metil}-lH-imidazol-5-il]-2-(2-tienil)metil-2-propenojske kisline ali njegova farmacevtsko sprejemljiva sol.A compound which is methanesulphonate (E) -3- [2-n-butyl-1 - {(4-carboxaphth-1-yl) methyl} -1H-imidazol-5-yl] 2-thienyl) methyl-2-propenoic acid or a pharmaceutically acceptable salt thereof. 2. Farmacevtski sestavek, označen s tem, da obsega farmacevtski nosilec in spojino po zahtevku 1.Pharmaceutical composition, characterized in that it comprises a pharmaceutical carrier and a compound according to claim 1. 3. Uporaba spojine po zahtevku 1 pri izdelavi zdravila za zdravljenje bolezni, kjer je činitelj angiotenzin II receptorski antagonizem.Use of a compound according to claim 1 in the manufacture of a medicament for the treatment of a disease wherein the effect is angiotensin II receptor antagonism. 4. Uporaba spojine po zahtevku 1 pri izdelavi zdravila za zdravljenje hipertenzije.Use of a compound of claim 1 in the manufacture of a medicament for the treatment of hypertension. 5. Uporaba spojine po zahtevku 1 pri izdelavi zdravila za zdravljenje kongestivne odpovedi srca.Use of a compound according to claim 1 in the manufacture of a medicament for the treatment of congestive heart failure. 6. Uporaba spojine po zahtevku 1 pri izdelavi zdravila za zdravljenje odpovedi ledvic.Use of a compound according to claim 1 in the manufacture of a medicament for the treatment of renal failure.
SI9200228A 1992-09-25 1992-09-25 Imidazolyl-alkenoic acids SI9200228B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SI9200228A SI9200228B (en) 1992-09-25 1992-09-25 Imidazolyl-alkenoic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI9200228A SI9200228B (en) 1992-09-25 1992-09-25 Imidazolyl-alkenoic acids

Publications (2)

Publication Number Publication Date
SI9200228A SI9200228A (en) 1994-03-31
SI9200228B true SI9200228B (en) 2001-12-31

Family

ID=20431002

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9200228A SI9200228B (en) 1992-09-25 1992-09-25 Imidazolyl-alkenoic acids

Country Status (1)

Country Link
SI (1) SI9200228B (en)

Also Published As

Publication number Publication date
SI9200228A (en) 1994-03-31

Similar Documents

Publication Publication Date Title
MX9504034A (en) Medical administering forms containing tioctic acid, or tioctic acid solid salts having improved release and bioavailability.
DE69534538D1 (en) Delayed release of peptides from pharmaceutical compositions
RU94045950A (en) Pharmaceutical preparation and method of its preparing
PT1227806E (en) PHARMACEUTICAL FORMULA CONTAINING TOLTERODINE AND ITS UTILIZATION
MA26471A1 (en) ARYLSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
CA2005986A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
BRPI0015567B8 (en) compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition
ATE424810T1 (en) A DELAYED-RELEASE TABLET CONTAINING A HYDROCOLLOID AND A CELLULOSE ETHER
RU2002100058A (en) 1-Methylcarbapenem Crystal Derivatives
ITMI941262A0 (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING (S)-2-(4- ISOBUTYLPHENYL) PROPIONIC ACID AS THE ACTIVE INGREDIENT
BE900564A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES.
FR2754177B1 (en) PHARMACEUTICAL MICROSPHERES OF VALPROIC ACID FOR ORAL ADMINISTRATION
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
JP2002522501A5 (en)
MA25432A1 (en) VETERINARY FORMULATION FOR THE ADMINISTRATION OF A DRUG INSOLUBLE IN WATER TO A TARGET ANIMAL BY A WATER DISTRIBUTION SYSTEM.
RU93047023A (en) ANIMOTENZINE-11 IMIDAZOLE ANTAGONISTS DERIVATIVES, THEIR PRODUCTION AND THERAPEUTIC USE
HU9301672D0 (en) Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
CA2005980A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
RU93049407A (en) Benzimidazole Derivatives and Medicinal Products with Antagonistic Against Angiotensin Action
CA2310028A1 (en) High drug load immediate and modified release oral dosage formulations and processes for their manufacture
SI9200228B (en) Imidazolyl-alkenoic acids
FR2759585B1 (en) PHARMACEUTICAL FORMULATIONS PRESENTED IN A DRY FORM FOR THE ORAL ADMINISTRATION OF A CYCLIC QUATERNARY AMMONIUM COMPOUND
IE780217L (en) 1,3,5-triazine-2,6-dione derivatives
RU2004112422A (en) ROUVASTATIN IN PREDEDENTIONAL CONDITIONS
YU87501A (en) Pharmaceutical complex

Legal Events

Date Code Title Description
IF Valid on the prs date